Marine JARY

Publications

Article dans une revue (16)

Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study Camille Evrard,Antoine Pelras,Simon Rivet,Jean-Baptiste Bachet,Olivier Dubreuilet al. Oncologist, 2025, 30 (6), ⟨10.1093/oncolo/oyaf125⟩ Article dans une revue hal-05574741v1
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study Thierry André,David Tougeron,Guillaume Piessen,Christelle de La Fouchardière,Christophe Louvetet al. Journal of Clinical Oncology, 2023, 41 (2), pp.255-265. ⟨10.1200/JCO.22.00686⟩ Article dans une revue hal-03975142v1
Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients (pts) with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma (OGA): The GERCOR NEONIPIGA phase II study Thierry Andre,David Tougeron,Guillaume Piessen,Christelle de La Fouchardiere,Christophe Louvetet al. Journal of Clinical Oncology, 2022, 40 (4), pp.244-244. ⟨10.1200/JCO.2022.40.4_suppl.244⟩ Article dans une revue hal-03657929v1
The immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study Marine Jary,Wen‐wei Liu,Dongyao Yan,Isaac Bai,Andrea Muranyiet al. Molecular Oncology, 2021, ⟨10.1002/1878-0261.13173⟩ Article dans une revue hal-03510003v1
Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment Brice Pastor,André Thierry,Julie Henriques,Isabelle Trouilloud,Christophe Tournigandet al. Molecular Oncology, 2021, 15 (9), pp.2401-2411. ⟨10.1002/1878-0261.12972⟩ Article dans une revue hal-03216431v1
Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients Laura Mansi,Laurie Spehner,Etienne Daguindau,Kevin Bouiller,Hamadi Almotlaket al. European Journal of Cancer, 2021, 150, pp.1-9. ⟨10.1016/j.ejca.2021.03.033⟩ Article dans une revue hal-03364202v1
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial Stefano Kim,Bruno Buecher,Thierry André,Marine Jary,François-Clément Bidardet al. BMC Cancer, 2020, 20 (1), pp.352. ⟨10.1186/s12885-020-06841-1⟩ Article dans une revue hal-03130294v1
Patients atteints d’un cancer gastrique localisé MSI/dMMR, pas de chimiothérapie mais une immunothérapie périopératoire : l’essai de phase II GERCOR NEONIPIGA vient d’être ouvert au recrutement Romain Cohen,Thomas Pudlarz,Marie-Line Garcia-Larnicol,Dewi Vernerey,Xavier Drayet al. Bulletin du Cancer, 2020, 107 (4), pp.438-446. ⟨10.1016/j.bulcan.2019.11.016⟩ Article dans une revue hal-02995557v1
Mesure de la réponse radiologique scannographique des cancers colorectaux métastatiques : état des lieux et perspectives Achille Fabre,Nicolas Badet,Paul Calame,Eric Delabrousse,Mylène Wespiseret al. Bulletin du Cancer, 2019, 106, pp.1029 - 1038. ⟨10.1016/j.bulcan.2019.08.013⟩ Article dans une revue hal-03488393v1
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study Stefano Kim,Eric François,Thierry André,Emmanuelle Samalin,Marine Jaryet al. Lancet Oncology, 2018, 19 (8), pp.1094 - 1106. ⟨10.1016/S1470-2045(18)30321-8⟩ Article dans une revue istex hal-01863908v1
Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment Sindy Vrecko,David Guenat,Patricia Mercier-Letondal,Hugues Faucheu,Magalie Dossetet al. Oncotarget, 2018, 9 (83), pp.35394-35407. ⟨10.18632/oncotarget.26247⟩ Article dans une revue hal-01953497v1
A systematic review of economic evaluation in pancreatic ductal adenocarcinoma Claire Gérard,Philippe Fagnoni,Angélique Vienot,Christophe Borg,Samuel Limatet al. European Journal of Cancer, 2017, 86, pp.207 - 216. ⟨10.1016/j.ejca.2017.08.035⟩ Article dans une revue inserm-01620966v1
Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells Jeanne Galaine,Guillaume Guillaume,Yves Guillaume,Romain Boidot,Emilie Picardet al. Journal of Immunology, 2016, 197 (5), pp.1597 - 1608. ⟨10.4049/jimmunol.1502633⟩ Article dans une revue hal-01407427v1
Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma. Marine Jary,Dewi Vernerey,Thierry Lecomte,Erion Dobi,François Ghiringhelliet al. Cancer Epidemiology, Biomarkers and Prevention, 2015, 24 (3), pp.603-12. ⟨10.1158/1055-9965.EPI-14-1059⟩ Article dans une revue inserm-01139951v1
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy. Frédéric Fiteni,Marine Jary,Franck Monnien,Thierry Nguyen,Eric Beohouet al. BMC Gastroenterology, 2013, pp.143 Article dans une revue inserm-01096384v1
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels. Stefano Kim,Erion Dobi,Marine Jary,Franck Monnien,Elsa Curtitet al. BMC Cancer, 2013, 13 (1), pp.611. ⟨10.1186/1471-2407-13-611⟩ Article dans une revue inserm-00922823v1